Genpharmasec Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 6.63 | 5.88 | 10.51 |
| Operating Expense | 5.51 | 5.07 | 10.04 |
| Net Profit | 1 | 0.59 | -0.05 |
| Net Profit Margin | 15.08 | 10.03 | -0.48 |
| Earning Per Share | 0.02 | 0.01 | TBA |
| EBIDTA | 1.08 | 0.66 | 0.09 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 6.63 |
| Operating Expense | 5.51 |
| Net Profit | 1.00 |
| Net Profit Margin | 15.08 |
| Earning Per Share | 0.02 |
| EBIDTA | 1.08 |
| Effective Tax Rate | TBA |
Invest in Genpharmasec Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 30.41 | 25.52 | 27.32 |
| Operating Expenses Annual | 30.25 | 25.26 | 27.84 |
| Operating Profit Annual | 0.88 | 0.36 | -0.43 |
| Interest Annual | 0.39 | 0.06 | TBA |
| Depreciation | 0.02 | 0.02 | 0.01 |
| Net Profit Annual | 0.05 | 1.12 | -0.21 |
| Tax Annual | 0.42 | -0.84 | -0.23 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 30.41 |
| Operating Expenses Annual | 30.25 |
| Operating Profit Annual | 0.88 |
| Interest Annual | 0.39 |
| Depreciation | 0.02 |
| Net Profit Annual | 0.05 |
| Tax Annual | 0.42 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.99 | 1.61 | 3.53 |
| Cash Flow from Operations | -2.27 | -3.06 | -2.34 |
| Cash Flow from Investing | -29.03 | 0.36 | 0.42 |
| Cash Flow from Financing | 47.89 | 3.08 | TBA |
| Cash Flow at the End | 18.58 | 1.99 | 1.61 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1.99 |
| Cash Flow from Operations | -2.27 |
| Cash Flow from Investing | -29.03 |
| Cash Flow from Financing | 47.89 |
| Cash Flow at the End | 18.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 2.86 | 1.41 | -1.57 |
| PBIT Margin (%) | 2.80 | 1.33 | -1.61 |
| PBT Margin (%) | -4.47 | -20.89 | -1.61 |
| Net PROFIT Margin (%) | 0.16 | 4.39 | -0.77 |
| Return On Networth / Equity (%) | 0.11 | 6.35 | TBA |
| Return On Networth /Employed (%) | 1.81 | 1.77 | TBA |
| Return On Assets (%) | 0.12 | 6.63 | -1.17 |
| Total Debt / Equity (X) | 0.08 | 0.10 | TBA |
| Asset Turnover Ratio (%) | 0.71 | 1.51 | 1.52 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 2.86 |
| PBIT Margin (%) | 2.80 |
| PBT Margin (%) | -4.47 |
| Net PROFIT Margin (%) | 0.16 |
| Return On Networth / Equity (%) | 0.11 |
| Return On Networth /Employed (%) | 1.81 |
| Return On Assets (%) | 0.12 |
| Total Debt / Equity (X) | 0.08 |
| Asset Turnover Ratio (%) | 0.71 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.10 | 0.10 | 0.10 |
| Total Current Assets Annual | 40.04 | 18.93 | 21.54 |
| Non Current Assets Annual | 30.44 | 0.95 | 0.11 |
| Total Shareholders Funds Annual | 64.57 | 15.33 | 15.37 |
| Total Assets Annual | 70.47 | 19.88 | 21.65 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.10 |
| Total Current Assets Annual | 40.04 |
| Non Current Assets Annual | 30.44 |
| Total Shareholders Funds Annual | 64.57 |
| Total Assets Annual | 70.47 |
EPS (INR)
Expected
0.01
Reported
0.01
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
